Concepedia

Laura Deedigan

LD

Statistics

Publications

7

Citations

425

H-Index

7

Active since

2008

Affiliations

Ollscoil na Gaillimhe – University of Galway(Current)

Orbsen Therapeutics (Ireland)

Laura Deedigan is an author at Ollscoil na Gaillimhe – University of Galway specializing in oncology, apoptosis, and cell signaling.

Publications per year

2008–2020

7

Publications

7

Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model

Andrea Mohr, Mark Lyons, Laura Deedigan et al. · Journal of Cellular and Molecular Medicine · 2008 · 111 citations · Full text

, , +16

Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells

Andrea Mohr, Stella Maris Albarenque, Laura Deedigan et al. · Stem Cells · 2010 · 98 citations · Full text

, , +17

Targeting stromal cell Syndecan‐2 reduces breast tumour growth, metastasis and limits immune evasion

Paul Loftus, Luke Watson, Laura Deedigan et al. · International Journal of Cancer · 2020 · 68 citations · Full text

, , +17

Syndecan-2–positive, Bone Marrow–derived Human Mesenchymal Stromal Cells Attenuate Bacterial-induced Acute Lung Injury and Enhance Resolution of Ventilator-induced Lung Injury in Rats

Claire Masterson, James Devaney, Shahd Horie et al. · Anesthesiology · 2018 · 56 citations

, , +17

Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects

Rui Yu, Laura Deedigan, Stella Maris Albarenque et al. · Cell Death and Disease · 2013 · 46 citations · Full text

, , +17

1–5 of 7